The cyclophilin inhibitor Debio 025 combined with PEG IFNα2a significantly reduces viral load in treatment-naïve hepatitis C patients-Reference-Cited by-同舟云学术

The cyclophilin inhibitor Debio 025 combined with PEG IFNα2a significantly reduces viral load in treatment-naïve hepatitis C patients

Published:2009-02-04 Issue:5 Volume:49 Page:1460-1468
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Flisiak Robert,Feinman Saya V.,Jablkowski Maciej,Horban Andrzej,Kryczka Wieslaw,Pawlowska Małgorzata,Heathcote Jenny E.,Mazzella Giuseppe,Vandelli Carmen,Nicolas-Métral Valérie,Grosgurin Pierre,Liz Jorge S.,Scalfaro Pietro,Porchet Hervé,Crabbé Raf

Publisher

Wiley

Subject

Hepatology

Reference15 articles.

1. Epidemiology of hepatitis C virus infection;Alter;World J Gastroenterol,2007

2. American Gastroenterological Association technical review on the management of hepatitis C;Dienstag;Gastroenterology,2006

3. Evaluation of a cyclophilin inhibitor in hepatitis C virus-infected chimeric mice in vivo;Inoue;HEPATOLOGY,2007

4. The non-immunosuppressive cyclosporin DEBIO-025 is a potent inhibitor of hepatitis C virus replication in vitro;Paeshuyse;HEPATOLOGY,2006

5. The cyclophilin inhibitor Debio-025 shows potent anti-hepatitis C effect in patients coinfected with hepatitis C and human immunodeficiency virus;Flisiak;HEPATOLOGY,2008

Cited by 211 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Cyclophilin Inhibitor Rencofilstat Decreases HCV-Induced Hepatocellular Carcinoma Independently of Its Antiviral Activity;Viruses;2023-10-17

2. The Cyclophilin Inhibitor Rencofilstat Decreases HCV-induced Hepatocellular Carcinoma Independently of Its Antiviral Activity;2023-08-20

3. Proline Isomerization: From the Chemistry and Biology to Therapeutic Opportunities;Biology;2023-07-14

4. β-Lactams and Ureas as Cross Inhibitors of Prokaryotic Systems;Applied Microbiology;2023-06-25

5. The role of cyclophilins in viral infection and the immune response;Journal of Infection;2022-10